Skip to content

Author

AkshatKumar Nigam

We have 2 of 32 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

#machine learning Preprint Oct 2026

D2ML: Models for Direct-to-Biology Small Molecule Screening

Assay-aware learning can use the full D2B assay sequence to guide multi-objective molecular optimization, and models tailored to the structure of D2B data can improve prediction and guide the discovery of more potent and selective compounds.

AkshatKumar Nigam, N. Amara, Hillary J. Dequina et al. · 0 citations
Open access Sep 2026

AI-enhanced adaptive virtual screening of large libraries for ligand discovery.

AdaptiveFlow enables drug discovery at unprecedented scale and supports the development of AI-driven methods, and identifies nanomolar inhibitors of two disease-relevant targets, ferroptosis suppressor protein 1 and poly(ADP-ribose) polymerase 1.

Domiziana Cecchini, AkshatKumar Nigam, Ming Tang et al. · 1 citation

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.